0001562180-24-001656.txt : 20240222 0001562180-24-001656.hdr.sgml : 20240222 20240222193417 ACCESSION NUMBER: 0001562180-24-001656 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freeman Kevin Lee CENTRAL INDEX KEY: 0001945797 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38993 FILM NUMBER: 24666794 MAIL ADDRESS: STREET 1: C/O HEALTH CATALYST, INC. STREET 2: 10897 SOUTH RIVER FRONT PARKWAY #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Health Catalyst, Inc. CENTRAL INDEX KEY: 0001636422 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] ORGANIZATION NAME: 06 Technology IRS NUMBER: 453337483 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 BUSINESS PHONE: 801-708-6800 MAIL ADDRESS: STREET 1: 10897 SOUTH RIVER FRONT PARKWAY, #300 CITY: SOUTH JORDAN STATE: UT ZIP: 84095 FORMER COMPANY: FORMER CONFORMED NAME: HQC Holdings, Inc. DATE OF NAME CHANGE: 20150312 4 1 primarydocument.xml PRIMARY DOCUMENT X0508 4 2024-02-20 false 0001636422 Health Catalyst, Inc. HCAT 0001945797 Freeman Kevin Lee C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 false true false false Chief Commercial Officer false Common Stock 2024-02-20 4 A false 110000.00 0.00 A 277810.00 D Common Stock 2024-02-20 4 A false 3334.00 0.00 A 281144.00 D Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2024 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments. Represents an award of 3,334 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Each PRSU represents a contingent right to receive one share of the Issuer's common stock. /s/Benjamin Landry, as Attorney-in-Fact 2024-02-22